相关实验视频
Updated: Jul 21, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
488
SYNPO2上调是鼻癌患者不良预后因素
Shih-Lun Chang1,2, Ching-Chieh Yang3,4, Hong-Yue Lai5,6,7
1Department of Otolaryngology, Chi Mei Medical Center, Tainan, Taiwan.
Medicine
|July 28, 2023
概括
在鼻癌 (NPC) 组织中,Synaptopodin-2 (SYNPO2) 的含量显著升高. 高SYNPO2表达与先进的NPC阶段相关,并预测生存率较差,表明其作为预后生物标志物的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 鼻癌 (NPC) 由于晚期诊断和转移,在生存方面存在挑战.
- 识别新的诊断和预后标志物对于改善NPC患者的治疗结果至关重要.
研究的目的:
- 研究NPC中细胞粘附和瘤发生相关基因的差异表达.
- 为了评估synaptopodin-2 (SYNPO2) 在鼻癌的预后价值.
主要方法:
- 差异基因表达分析专注于细胞粘附和瘤发生.
- 在NPC组织中SYNPO2表达的免疫组织化学分析.
- 与临床病理特征和生存结果的相关性分析,使用皮尔森千平方和考克斯比例危险模型.
主要成果:
- 与非瘤组织相比,NPC组织中的SYNPO2表达显著更高.
- 较高的SYNPO2水平与晚期疾病相关 (P=.006).
- 高SYNPO2表达与较差的特定疾病生存率 (HR=1.968,P=.012) 和局部无复发生存率 (HR=3.386,P=.001) 相相关.
结论:
- 在鼻癌中,SYNPO2被上调.
- 在NPC患者中,SYNPO2作为潜在的独立预后生物标志物用于预测NPC患者的生存和复发.
相关概念视频
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K

